QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NYSE:CLB

Core Laboratories - CLB Price Target & Analyst Ratings

$20.75
+0.67 (+3.34%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$20.26
$21.27
50-Day Range
$20.08
$26.55
52-Week Range
$13.19
$34.08
Volume
435,096 shs
Average Volume
371,207 shs
Market Capitalization
$967.57 million
P/E Ratio
50.61
Dividend Yield
0.19%
Price Target
$21.83

Core Laboratories Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$21.83
5.18% Upside
High Prediction$26.00
Average Prediction$21.83
Low Prediction$20.00
TypeCurrent
3/20/22 to 3/20/23
1 Month Ago
2/18/22 to 2/18/23
3 Months Ago
12/20/21 to 12/20/22
1 Year Ago
3/20/21 to 3/20/22
Consensus Rating
Hold
Hold
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$21.83$21.83$19.58$28.88
Predicted Upside5.18% Upside-7.09% Downside-5.64% Downside-12.37% Downside
Get Core Laboratories Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

CLB Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Core Laboratories Stock vs. The Competition

TypeCore LaboratoriesOils/Energy CompaniesS&P 500
Consensus Rating Score
1.50
2.58
2.47
Consensus RatingHoldBuyHold
Predicted Upside3.93% Upside179.55% Upside22.67% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/7/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$21.00 ➝ $26.00-0.19%
1/9/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral
9/26/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$20.00+43.78%
7/26/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$26.00 ➝ $20.00+15.61%
4/18/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$19.50 ➝ $21.30-36.63%
1/11/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform
12/18/2020JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$17.00 ➝ $18.00-30.15%
12/15/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$16.00 ➝ $30.00+6.53%
11/11/2020Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform$26.00 ➝ $20.00+10.38%
9/29/2020ABN Amro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
7/16/2020Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Vaibhav Vaishnav
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSector Outperform ➝ Sector Perform$19.00-11.17%
4/27/2020Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
(Data available from 3/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CLB Price Target - Frequently Asked Questions

What is Core Laboratories's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Core Laboratories stock is Hold based on the current 2 sell ratings and 2 hold ratings for CLB. The average twelve-month price prediction for Core Laboratories is $21.83 with a high price target of $26.00 and a low price target of $20.00. Learn more on CLB's analyst rating history.

Do Wall Street analysts like Core Laboratories more than its competitors?

Analysts like Core Laboratories less than other Oils/Energy companies. The consensus rating for Core Laboratories is Hold while the average consensus rating for oils/energy companies is Buy. Learn more on how CLB compares to other companies.

Is Core Laboratories being upgraded by Wall Street analysts?

Over the previous 90 days, Core Laboratories's stock had 1 upgrade by analysts.

Does Core Laboratories's stock price have much downside?

According to analysts, Core Laboratories's stock has a predicted downside of -7.09% based on their 12-month price targets.

What analysts cover Core Laboratories?

Core Laboratories has been rated by Bank of America, and Citigroup in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:CLB) was last updated on 3/20/2023 by MarketBeat.com Staff